首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1439626

人工水晶體 - 全球市場考量、競爭格局、市場預測（2030 年）

Intraocular Lens - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

預計，2023年全球人工水晶體市場規模將達38.5億美元，到2030年將達到51.3億美元，2024-2030年預測期間複合年增長率為4.89%。眼部疾病盛行率上升、世界各國政府加強控制和治療失明、人工水晶體技術進步、老年人口數量增加等是人工水晶體需求快速成長的主要原因。預計將有助於擴大產品需求，進而推動2024-2030 年預測期內人工水晶體市場的成長。

人工水晶體市場動態

由於多種原因，人工水晶體市場的產品需求不斷增加，其中主要原因之一是眼部疾病的盛行率不斷增加。屈光不正、老年黃斑部病變、白內障、糖尿病視網膜病變和青光眼等眼部疾病的盛行率日益增加，是人工水晶體市場特別重要的驅動因素。大多數60歲以上的人患有各種類型的慢性眼疾，需要進行眼科手術。視力障礙是影響身心健康的全球性健康問題。視力受損的人特別容易患慢性病、意外、社交退縮、憂鬱和死亡。根據世界衛生組織 (WHO) 的數據，2020 年至少有 22 億人患有近距離視力或遠端視力障礙。據同一消息來源稱，到 2020 年，大約有 10 億人患有屈光不正、白內障、青光眼以及由於角膜混濁導致的中度屈光不正而未得到治療。因此，如此龐大的眼疾患者群體使其成為人工水晶體市場公司的潛在目標。

此外，根據2019年世界衛生報告，全球每年約有1000萬例白內障手術，其中人工水晶體廣泛使用，手術率每年每百萬人100至100例，在6000例之間波動。因此，由於眼部疾病盛行率的增加和白內障患者數量的增加，人工水晶體的全球滲透率將在預測期內（2024-2030年）刺激全球人工水晶體市場。

另一個可能推動人工水晶體市場成長的因素是人工水晶體開發的技術進步。由於眼部疾病盛行率不斷上升，對人工水晶體的需求不斷增加，企業可以增加對人工水晶體技術進步的投資。

公司與眼科界保持持續聯繫，不時進行調查，以瞭解患者需求並相應調整研發。活躍在這一領域的公司不斷致力於推出各種材料、形狀和尺寸的人工水晶體，以解決術後亮度和術後後囊膜渾濁 (PCO) 等問題。這些進步體現在市場上的各種尖端人工水晶體中，引入了新的水晶體設計，例如藍光截止人工水晶體、消色差人工水晶體和復曲面人工水晶體。術後光功率變化為患者提供了更個人化的方法，使他們能夠接受根據其視力矯正方面的特定需求量身定制的治療。

技術進步促進了新型人工水晶體的發展，例如三焦點、四焦點、擴展景深 (EDOF) 和可調節人工水晶體，這些晶狀體連同改進的光學元件和像差分佈，可以在任何距離使用。現在我們可以提供不戴眼鏡的視力。人工水晶體的優點也轉化為市場的高需求，越來越多的公司在臨床試驗中開發採用新技術的人工水晶體就證明了這一點，例如 Anew Optics 的 Zephyr IOL。例如，美國推出的新技術多焦點人工水晶體是愛爾康 PanOptix，這是一種具有出色遠、中、近距離視力的三焦點水晶體。其他人工水晶體正在 FDA 批准中，具有增強的選項，可優化覆蓋範圍並最大限度地減少光暈和眩光。 2022年，IC8（AcuFocus）完成FDA臨床試驗並向FDA提交上市前核准申請。因此，隨著這些技術的進步，更多的產品將在市場上推出，並且在預測期內人工水晶體市場的成長前景是光明的。

本報告研究和分析了全球人工水晶體市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

推動人工水晶體市場的因素
- 眼部疾病盛行率上升
- 世界各國政府加強控制和治療失明
- 人工水晶體技術的進步
- 老年人口迅速增加
人工水晶體市場的抑制因素與挑戰
- 與人工水晶體相關的術後併發症
- 缺乏優質鏡片覆蓋範圍
人工水晶體市場機遇
- 新興市場尚未開發的潛力
- 提高對人工水晶體的認識

第5章人工水晶體市場波特五力分析

第6章COVID-19對人工水晶體市場的影響分析

第7章人工水晶體市場佈局

依產品類型
- 單焦點人工水晶體
- 優質人工水晶體
- 其他
依材質
- 聚甲基丙烯酸甲酯
- 疏水性丙烯酸人工水晶體
- 親水性丙烯酸人工水晶體
按最終用戶
- 醫院
- 門診手術中心
- 眼科診所
按地區
- 北美
- 歐洲
- 亞太地區
- 其他領域

第 8 章人工水晶體市場：全球公司佔有率分析 - 3 至 5 家主要公司

第9章人工水晶體市場公司及產品概況

Johnson & Johnson
HOYA GROUP
Alcon Inc
Carl Zeiss Meditec AG
Bausch & Lomb
Rayner Intraocular Lenses Limited
Eyekon Medical Inc
Lenstec, Inc
HumanOptics AG
STAAR Surgical Company
Aurolab
PhyIOL S.A.
Care Group
Tekia Inc
Omni Lens Pvt. Ltd
MORCHER® GmbH
Ophtec BV
SIFI S.p.A.
Excellent Hi-Care Pvt. Ltd
Hanita Lenses

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0462

Intraocular Lenses Market By Product Type (Monofocal IOLs [Aspheric Monofocal IOLs And Spheric Monofocal IOLs], Premium Iols [Multifocal Iols, Accomodating Iols, And Extended Depth-Of-Focus IOLs], And Others), By Material (Polymethyl Methacrylate, Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Ophthalmology Clinics), and by geography is expected to grow at a steady CAGR (forecast period- 2024-2030) owing to increasing prevalence of ocular diseases rising technological advancements in new intraocular lenses

Global Intraocular Lens Market was valued at USD 3.85 billion in 2023, growing at a CAGR of 4.89% during the forecast period from 2024 to 2030 to reach USD 5.13 billion by 2030. The demand for intraocular lenses is witnessing a surge primarily due to the rising prevalence of eye diseases, increasing initiatives by various governments across the globe in controlling and treating blindness, technological advancements in IOLs, and the increasing geriatric population who are more susceptible to ocular ailments which are expected to contribute in the growing product demand thereby boosting the growth of the of the intraocular lens market during the forecast period from 2024-2030.

Intraocular Lens Market Dynamics:

The intraocular lenses market is experiencing increased product demand for a variety of reasons, one of the main reasons being the increase in the prevalence of ocular diseases. Increasing prevalence of eye diseases such as refractive error, age-related macular degeneration, cataracts, diabetic retinopathy, and glaucoma is a major driver of the intraocular lens market in particular. The majority of people over the age of 60 are affected by various types of eye problems that are chronic and require eye surgery. Visual impairment is a global health problem that affects physical and mental health. Visually impaired people are at particular risk of chronic illness, accidents, social withdrawal, depression, and death. According to the World Health Organization, in 2020, at least 2.2 billion people suffered from short- or long-distance visual impairment. According to the same source, in 2020, about 1 billion people had moderate refractive error due to untreated refractive error (88.4 million), cataract (94 million), glaucoma (7.7 million), and corneal opacity (4.2 million). Therefore, the presence of such large patient pool with ocular diseases are potential targets for companies operating in the IOL market.

Additionally, according to the 2019 World Health Report, approximately 10 million cataract surgeries are performed worldwide each year wherein IOLs are extensively used, and the rate of surgeries fluctuates between 100 and 6,000 per million people annually. Therefore, the increasing global acceptance of IOL and the increasing number of patients suffering from cataracts due to the increased prevalence of eye diseases will stimulate the global intraocular lens market during the forecast period (2024-2030).

Another contributing factor that may be responsible for the growth of the intraocular lens market is the technological advancements in the development of IOLs. Due to the rising prevalence of eye disease has increased the demand for IOLs, allowing companies to invest more in the technological advances in intraocular lenses.

Companies are in constant contact with the ophthalmology community and conduct occasional surveys to understand the needs of their patients and adjust their R&D accordingly. Companies operating in this domain are continuously working on the introduction of IOLs of various materials, shapes and sizes to address issues such as post-operative glistening and post-operative posterior capsule opacity (PCO). These advances were reflected by the variety of state-of-the-art IOLs available in the market, introducing new design lenses such as blue light blocking IOLs, aberration-free IOLs, and toric IOLs. Postoperative changes in optical power offer a more personalized approach for patients thereby enabling them to receive treatment catering to their specific needs in terms of vision correction.

Technological advancements have led to the development of newer IOLs comprising trifocal, quadrifocal, extended-depth-of-focus (EDOF) and adjustable IOLs that are capable in providing spectacle-free vision at all distances, along with improvement in optics and aberration profiles. Advantages associated with IOLs have also translated into their high demand in the market which is evident by the fact that more companies are developing IOLs with new technology that are in clinical trials such as Zephyr IOL by Anew Optics. For instance, one of the latest technologically advanced multifocal IOLs available in the United States is the Alcon PanOptix, a trifocal lens with good far vision, intermediate vision, and near vision. Other IOLs are in the FDA-approved pipeline with enhanced options to optimize range and minimize halos and glare. In 2022, IC8 (AcuFocus) completed the FDA's clinical trials and submitted a pre-marketing approval application to the FDA. Therefore, these technological advancements have led to the more products reaching the market thereby presenting a positive growth outlook for the IOL market during the forecast period.

However, limitations associated with post-operative complications associated with intraocular lens and lack of coverage of premium lens may prove to be challenging factors for the intraocular lenses market growth.

Along with the factors mentioned above, the intraocular lenses market witnessed a period of slow growth due to the COVID-19 pandemic. The lockdown implemented by various governments worldwide to curb the spread of the COVID-19 infection resulted in suspension of various surgeries and outpatient consultations across virtually all medical specialties including ophthalmology. The elective procedures were postponed as the number of new COVID-19 cases had reached a peak, many clinics were closed, and the cataract surgeries were down by approximately half of the surgical volumes compared to previous years resulting in the low demand of IOLs. However, the approval of various COVID-19 vaccines and the efforts in the direction of mass vaccination has paved the way for recovery in revenue generation in the IOLs market, thereby presenting a positive growth outlook of the IOLs market during the forecast period.

Intraocular Lens Market Segment Analysis:

Intraocular Lenses Market by Product Type (Monofocal IOLs [Aspheric Monofocal IOLs and Spheric Monofocal IOLs], Premium IOLs [Multifocal IOLs, Accommodating IOLs, And Extended Depth-Of-Focus IOLs], and Others), by Material (Polymethyl Methacrylate, Hydrophobic Acrylic IOLs, Hydrophilic Acrylic IOLs, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Ophthalmology Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the Intraocular Lens Market, the monofocal IOLs category is expected to hold the largest market share in the IOLs market during the forecast period. Monofocal IOLs are further sub-segmented into aspheric monofocal IOLs and spheric monofocal IOLs. Between the two, aspherical monofocal IOLs are expected to register a faster growth in CAGR during the forecast period. This can be attributed to the features offered by these type of lenses such as improved contrast sensitivity, superior night driving ability, and enhanced functional vision. These features have been immensely popular among end users thereby resulting in their higher adoption.

Moreover, aspheric monofocal IOLs are easy to insert, induces limited or zero spheric aberration, and create very effective contrast sensitive optical image for patients. In addition to that, the presence of major players such as ZIESS with products like ZEISS CT LUCIA, ZEISS CT ASPHINA and Alcon with product like Alcon IQ Aspheric IOL dominate the market.

Therefore, all the factors mentioned above indicate towards the popularity of aspheric monofocal IOLs in the market, thereby making them the most popular product type in monofocal IOLs category.

Asia-Pacific is expected to register fastest growth in the Overall Intraocular Lenses Market:

Among all the regions, Asia-Pacific is expected to account for the fastest growth in terms of CAGR with 5.90% in the intraocular lenses market. The key driving factors of the Asia -Pacific Intraocular Lens Market are increasing prevalence of ocular diseases, rising investments and big collaborative expansions by key players in the region. Moreover, the increased healthcare awareness is also driving the growth of the APAC Intraocular Lenses market.

According to the data cited by the World Health Organization, in 2020, an estimated 596 million people worldwide had distant visual impairment, of which 43 million were blind. The majority of those affected (90%) live in low- and middle-income countries (LMIC). The study further mentioned that South Asia had the highest overall age-standardized prevalence of moderate to severe vision impairment. It was reported that the highest number of cases associated with blindness was observed in South Asia (11.9 million) followed by East Asia (9.1 million), and Southeast Asia (5.9 million) which was attributed to the presence of large population in the region, in general. The data further stated that majority of the cases associated with vision impairment were related with cataracts. Therefore, the presence of large patient pool has prompted international organizations and governments to provide better access to eye care thereby boosting the demand for IOLs in the region.

Moreover, due to the presence of large patient population of ocular diseases in the APAC countries, VISION 2020, an initiative by the World Health Organization and the International Agency for the Prevention of Blindness was launched in 1999. Under this initiative, which was spread over the years, many countries devised national plans in order to deal with the disease burden associated with ocular diseases. For instance, in 2011, Lions Clubs International Foundation (LCIF), in partnership with the People's Republic of China, initiated a new phase of their campaign in China known as SightFirst China Action (SFCA), which aims at preventing blindness. Since its formation in 1997, the foundation invested more than USD 30.8 million for more than 5 million cataract surgeries and upgrading of 300 eye care institutions and above. In addition, the Chinese government-funded more than USD 200 million to support their campaign.

Therefore, such efforts in the direction of providing proper eye care to such large patient population in the region by offering accessible healthcare services and collaborations among manufacturers and organizations are expected to stimulate the growth of the APAC intraocular lens market.

Intraocular Lenses Market Key Players:

Some of the key market players operating in the intraocular lenses market includes Johnson & Johnson, HOYA GROUP, Alcon Inc, Carl Zeiss Meditec AG, Bausch & Lomb, Rayner Intraocular Lenses Limited, Eyekon Medical Inc, Lenstec, Inc, HumanOptics AG, STAAR Surgical Company, Aurolab, PhyIOL S.A., Care Group, Tekia Inc, Omni Lens Pvt Ltd, MORCHER? GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt. Ltd., Hanita Lenses and others.

Recent Developmental Activities in Intraocular Lens Market:

In September 21, 2022, ZEISS Medical Technology introduced industry-first, integrated solutions that bring further value to the ZEISS Medical Ecosystem at ZEISS Innovation Week. The newly introduced ZEISS CT LUCIA 621* monofocal IOL features the patented ZEISS Optic (ZO) Asphericity Concept with its uniquely forgiving design to deliver excellent visual outcomes for a broad range of patients and surgical situations.

In February 2022, Johnson & Johnson Vision received FDA approval for next-generation monofocal intraocular lens - Tecnis Eyhance(TM) and Tecnis Eyhance(TM) Toric Ii IOLS, for the treatment of cataract patients.

In January 07, 2022 Alcon Inc commercially launched the first and only non-diffractive extended depth of focus intraocular lens (IOL) in the US - the AcrySof? IQ VivityTM IOL (Vivity).

Key Takeaways from the Intraocular Lens Market Report Study

Market size analysis for current intraocular lenses market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the intraocular lenses market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Intraocular Lens Market.

Various opportunities available for the other competitor in the Intraocular Lens Market space.

What are the top performing segments in 2023? How these segments will perform in 2030?

Which is the top-performing regions and countries in the current intraocular lenses market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for intraocular lenses market growth in the coming future?

Target Audience who can be benefited from this Intraocular Lenses Market Report Study

Intraocular Lens products providers

Research organizations and consulting companies

Intraocular Lens-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in intraocular lenses

Various End-users who want to know more about the Intraocular Lens market and latest technological developments in the Intraocular Lens market.

Frequently Asked Questions for Intraocular Lens Market:

1. What is an Intraocular Lens?

An intraocular lens (IOL) is an implant which acts a replacement for the natural lens of eyes and takes over the image-focusing function in the eye.

2. What is the market for Global Intraocular Lens?

Global Intraocular Lens Market was valued at USD 3.85 billion in 2023, growing at a CAGR of 4.89% during the forecast period from 2024 to 2030 to reach USD 5.13 billion by 2030.

3. What are the drivers for Global Intraocular Lens Market?

The demand for intraocular lenses is witnessing a surge primarily due to certain market growth drivers such as the rising prevalence of eye diseases, increasing initiatives by various governments across the globe in controlling and treating blindness, technological advancements in IOLs, and the increasing geriatric population who are more susceptible to ocular ailments which are expected to contribute in the growing product demand thereby boosting the growth of the of the intraocular lens market during the forecast period from 2024-2030.

4. Who are the key players operating in Global Intraocular Lens Market?

5. Which region will register the fastest growth in Intraocular Lens market?

APAC is predicted to register the fastest growth the intraocular lenses market because of the high prevalence of diabetes, presence of large patient population suffering from ocular diseases, rising investments and big collaborative expansions by key players in the region. Moreover, the increased healthcare awareness is also driving the growth of the APAC Intraocular Lenses market.

1.Intraocular Lens Market Report Introduction

2.Intraocular Lens Market Executive Summary

2.1 Scope of the Study
2.2 Market at Glance
2.3 Competitive Assessment
2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

3.1 The United States
3.2 Europe
3.3 Japan
3.4 China

4. Intraocular Lens Market Key Factors Analysis

4.1 Intraocular Lens Market Drivers
- 4.1.1 Rising Prevalence of Eye Diseases
- 4.1.2 Increasing Initiatives by Various Governments Across the Globe in Controlling and Treating Blindness
- 4.1.3 Technological Advancements in IOLs
- 4.1.4 Surge in Geriatric Population
4.2 Intraocular Lens Market Restraints and Challenges
- 4.2.1 Post-operative Complications Associated with Intraocular Lens
- 4.2.2 Lack of Coverage of Premium Lens
4.3 Intraocular Lens Market Opportunities
- 4.3.1 Untapped Potential of Emerging Markets
- 4.3.2 Increasing awareness Toward Intraocular Lens

5. Intraocular Lens Market Porter's Five Forces Analysis

5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Consumers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Intraocular Lens Market

7. Intraocular Lens Market Layout

7.1 By Product Type
- 7.1.1 Monofocal Intraocular Lenses
  - 7.1.1.1 Aspheric Monofocal IOLs
  - 7.1.1.2 Spheric Monofocal IOLs
- 7.1.2 Premium IOLS
  - 7.1.2.1 Multifocal IOLs
  - 7.1.2.2 Accommodating IOLs
  - 7.1.2.3 Extended Depth-of-Focus IOLs
- 7.1.3 Others
7.2 By Material
- 7.2.1 Polymethyl Methacrylate
- 7.2.2 Hydrophobic Acrylic IOLs
- 7.2.3 Hydrophilic Acrylic IOLs
- 7.2.4 Others
7.3 By End User
- 7.3.1 Hospitals
- 7.3.2 Ambulatory Surgical Centers
- 7.3.3 Ophthalmology Clinics
7.4 By Geography
- 7.4.1 North America
  - 7.4.1.1 North America Intraocular Lens Market, by Product Type
  - 7.4.1.2 North America Intraocular Lens Market, by Material
  - 7.4.1.2 North America Intraocular Lens Market, by End User
  - 7.4.1.4 North America Intraocular Lens Market, by Country
  - 7.4.1.4.1 United States
  - 7.4.1.4.2 Canada
  - 7.4.1.4.3 Mexico
- 7.4.2 Europe
  - 7.4.2.1 Europe Intraocular Lens Market, by Product Type
  - 7.4.2.2 Europe Intraocular Lens Market, by Material
  - 7.4.2.2 Europe Intraocular Lens Market, by End User
  - 7.4.2.4 Europe Intraocular Lens Market, by Country
  - 7.4.2.4.1 France
  - 7.4.2.4.2 Germany
  - 7.4.2.4.3 United Kingdom
  - 7.4.2.4.4 Italy
  - 7.4.2.4.5 Spain
  - 7.4.2.2.6 Russia
  - 7.4.2.2.7 Rest of Europe
- 7.4.3 Asia-Pacific
  - 7.4.3.1 Asia-Pacific Intraocular Lens Market, by Product Type
  - 7.4.3.2 Asia-Pacific Intraocular Lens Market, by Material
  - 7.4.3.2 Asia-Pacific Intraocular Lens Market, by End User
  - 7.4.3.4 Asia-Pacific Intraocular Lens Market, by Country
  - 7.4.3.4.1 China
  - 7.4.3.4.2 Japan
  - 7.4.3.4.3 India
  - 7.4.3.4.4 Australia
  - 7.4.3.4.5 South Korea
  - 7.4.3.4.6 Rest of Asia Pacific
- 7.4.4 Rest of the World (RoW)
  - 7.4.4.1 RoW Intraocular Lens Market, by Product Type
  - 7.4.4.2 RoW Intraocular Lens Market, by Material
  - 7.4.4.2 RoW Intraocular Lens Market, by End User
  - 7.4.4.4 RoW Intraocular Lens Market, by Region
  - 7.4.4.4.1 Middle East
  - 7.4.4.4.2 Africa
  - 7.4.4.4.3 South America

8. Intraocular Lens Market Global Company Share Analysis - Key 3-5 Companies

9. Intraocular Lens Market Company and Product Profiles

9.1 Johnson & Johnson
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4 Product Listing
- 9.1.5. Entropy
9.2 HOYA GROUP
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4 Product Listing
- 9.2.5. Entropy
9.3 Alcon Inc
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4 Product Listing
- 9.3.5. Entropy
9.4 Carl Zeiss Meditec AG
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4 Product Listing
- 9.4.5. Entropy
9.5 Bausch & Lomb
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4 Product Listing
- 9.5.5. Entropy
9.6 Rayner Intraocular Lenses Limited
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4 Product Listing
- 9.6.5. Entropy
9.7 Eyekon Medical Inc
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4 Product Listing
- 9.7.5. Entropy
9.8 Lenstec, Inc
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4 Product Listing
- 9.8.5. Entropy
9.9 HumanOptics AG
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4 Product Listing
- 9.9.5. Entropy
9.10 STAAR Surgical Company
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4 Product Listing
- 9.10.5. Entropy
9.11 Aurolab
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4 Product Listing
- 9.11.5. Entropy
9.12 PhyIOL S.A.
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4 Product Listing
- 9.12.5. Entropy
9.13 Care Group
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4 Product Listing
- 9.13.5. Entropy
9.14 Tekia Inc
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4 Product Listing
- 9.14.5. Entropy
9.15 Omni Lens Pvt. Ltd
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4 Product Listing
- 9.15.5. Entropy
9.16 MORCHER® GmbH
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4 Product Listing
- 9.16.5. Entropy
9.17 Ophtec BV
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4 Product Listing
- 9.17.5. Entropy
9.18 SIFI S.p.A.
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4 Product Listing
- 9.18.5. Entropy
9.19 Excellent Hi-Care Pvt. Ltd
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4 Product Listing
- 9.19.5. Entropy
9.20 Hanita Lenses
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4 Product Listing
- 9.20.5. Entropy